These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38814065)

  • 1. Clinical risk factors and outcomes of carbapenem-resistant
    Kong H; Hu Z; Zhang L; Chen Q; Yang L; Li J; Tian B; Chai Y; Feng X
    Microbiol Spectr; 2024 Jul; 12(7):e0422823. PubMed ID: 38814065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
    Meng X; Liu S; Duan J; Huang X; Zhou P; Xiong X; Gong R; Zhang Y; Liu Y; Fu C; Li C; Wu A
    BMC Infect Dis; 2017 Jan; 17(1):82. PubMed ID: 28095785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population genomic analysis reveals the emergence of high-risk carbapenem-resistant Escherichia coli among ICU patients in China.
    Zhang R; Li Y; Chen J; Liu C; Sun Q; Shu L; Chen G; Wang Z; Wang S; Li R
    J Infect; 2023 Apr; 86(4):316-328. PubMed ID: 36764393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.
    Park Y; Choi Q; Kwon GC; Koo SH
    J Clin Lab Anal; 2020 Feb; 34(2):e23041. PubMed ID: 31541503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China.
    Sun JD; Huang SF; Yang SS; Pu SL; Zhang CM; Zhang LP
    Clin Microbiol Infect; 2015 May; 21(5):469.e1-10. PubMed ID: 25649300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Enterobacter cloacae complex in a tertiary Hospital in Northeast China, 2010-2019.
    Chen J; Tian S; Nian H; Wang R; Li F; Jiang N; Chu Y
    BMC Infect Dis; 2021 Jun; 21(1):611. PubMed ID: 34174823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rising Tide of Antibiotic Resistance: A Study on Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae.
    Ejaz H; Qamar MU; Farhana A; Younas S; Batool A; Lone D; Atif M; Alruways MW; Alruwaili M; Hamad I; Selim S; Mazhari BBZ; Farooq A; Junaid K
    J Clin Lab Anal; 2024 May; 38(10):e25081. PubMed ID: 38884333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
    Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
    Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.
    Ding Y; Wang Y; Hsia Y; Sharland M; Heath PT
    Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):36. PubMed ID: 31727088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant
    Gomez-Simmonds A; Annavajhala MK; Wang Z; Macesic N; Hu Y; Giddins MJ; O'Malley A; Toussaint NC; Whittier S; Torres VJ; Uhlemann AC
    mBio; 2018 May; 9(3):. PubMed ID: 29844109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.
    Jeon MH; Choi SH; Kwak YG; Chung JW; Lee SO; Jeong JY; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):402-6. PubMed ID: 18993012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of extended spectrum β-lactamase and carbapenemase genes carried by carbapenem-resistant Enterobacter cloacae in a Chinese university hospital.
    Cui L; Zhao J; Lu J
    Turk J Med Sci; 2015; 45(6):1321-8. PubMed ID: 26775390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.
    Mahalingam N; Manivannan B; Khamari B; Siddaramappa S; Adak S; Bulagonda EP
    Med Princ Pract; 2018; 27(5):428-435. PubMed ID: 29739004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Phenotypic Study of Carbapenem Resistant E. coli.
    Aziz FN
    Clin Lab; 2018 Jul; 64(7):1129-1136. PubMed ID: 30146823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Johnson JK; Robinson GL; Pineles LL; Ajao AO; Zhao L; Albrecht JS; Harris AD; Thom KA; Furuno JP
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National genomic epidemiology investigation revealed the spread of carbapenem-resistant Escherichia coli in healthy populations and the impact on public health.
    Li Y; Zhang Y; Sun X; Wu Y; Yan Z; Ju X; Huang Y; Zhou H; Wang Z; Wang S; Zhang R; Li R
    Genome Med; 2024 Apr; 16(1):57. PubMed ID: 38627827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.